A Clinical Study to Evaluate the Efficacy of Vasadi Ghrita Aschyotana in Management of Arjun W.S.R Subconjunctival Haemorrhage

Background: Arjuna, described in Ayurvedic literature as a Shuklagata Roga, presents with a painless red discoloration of the ocular surface and can be correlated clinically with subconjunctival haemorrhage. Although subconjunctival haemorrhage is generally self-limiting in modern ophthalmology, its cosmetic appearance and associated ocular discomfort may require therapeutic management. Ayurveda recommends Aschyotana as an important local therapeutic procedure in Netra Rogas. Aim: To evaluate the efficacy of Vasadi Ghrita Aschyotana in the management of Arjuna with special reference to subconjunctival haemorrhage. Materials and Methods: A clinical study was conducted on 15 patients aged 18–60 years presenting with signs and symptoms of Arjuna (subconjunctival haemorrhage). Vasadi Ghrita, containing Vasa, Yashtimadhu, and Goghrita, was administered as Aschyotana at a dose of two drops four times daily at four-hour intervals for 10 days. Clinical assessment was performed using parameters including Netra Daha, Netra Toda, Prakash Asahatva, Netra Araktata, and Netra Shopha. The observations before and after treatment were statistically assessed. Results: Statistically significant improvement was observed in all assessed clinical parameters (p < 0.05). The percentage relief was 72.72% in Netra Daha, 73.50% in Netra Toda, 77.77% in Prakash Asahatva, 69.23% in Netra Araktata, and 80.92% in Netra Shopha. Overall, 40% of patients showed marked improvement, 46.67% showed moderate improvement, and 13.33% showed mild improvement. No patient was categorized as having no improvement. 5-5-73 Conclusion: The present clinical study indicates that Vasadi Ghrita Aschyotana may be effective in reducing the clinical symptoms associated with Arjuna (subconjunctival haemorrhage). Maximum relief was observed in eyelid swelling and photophobia. The findings support the therapeutic potential of Vasadi Ghrita Aschyotana and provide clinical evidence for its use in the management of Arjuna.